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Gene expressions of cationic amino acid-based lipids having a spacer between the cationic head
group and hydrophobic moieties and examined the inﬂuence of the spacer on a liposome gene delivery
system. As a comparable spacer, a hydrophobic spacer with a hydrocarbon chain composed of 0, 3, 5, 7, or 11
carbons, and a hydrophilic spacer with an oxyethylene chain (10 carbon and 3 oxygen molecules) were
investigated. Plasmid DNA (pDNA)-encapsulating liposomes were prepared by mixing an ethanol solution of
the lipids with an aqueous solution of pDNA. The zeta potentials and cellular uptake efﬁciency of the cationic
liposomes containing each synthetic lipid were almost equivalent. However, the cationic lipids with the
hydrophobic spacer were subject to fuse with biomembrane-mimicking liposomes. 1,5-Dihexadecyl-N-lysyl-
N-heptyl-L-glutamate, having a seven carbon atom spacer, exhibited the highest fusogenic potential among
the synthetic lipids. Increased fusion potential correlated with enhanced gene expression efﬁciency. By
contrast, an oxyethylene chain spacer showed low gene expression efﬁciency. We conclude that a
hydrophobic spacer between the cationic head group and hydrophobic moieties is a key component for
improving pDNA delivery.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
Gene therapy has become an important alternative approach for
the treatment of diseases that until recently were considered
incurable. Viral vectors, such as adenovirus vectors, adeno-associated
virus vectors or retrovirus vectors, have been utilized in clinical trials.
However, some side effects including immunoresponse and infection
have been reported [1,2]. Therefore, the development of non-viral
vectors for practical gene therapy is keenly awaited.
Cationic liposomes are mostly utilized as a gene carrier for plasmid
DNA (pDNA) [3–5], antisense oligonucleotides [6] or small interfering
RNA (siRNA) [7,8]. For transfection of cultured cells, cationic
liposomes generally form lipoplexes with nucleic acids by electrostatic
interaction between the positively charged liposomes and the
negatively charged nucleic acids. The resulting complex is then
applied to the cells to bring about gene expression. Lipoplexes have
been applied both in vitro and in vivo [9,10]. However, clinical studies
using lipoplexes suggested that the DNA was subject to rapid
degradation via biological defense systems such as endogenous
DNase activity. The DNA degradation inevitably leads to a reductionnce and Medical Bioscience,
, Waseda University (TWIns),
324; fax: +81 3 5369 7324.
ll rights reserved.of gene expression efﬁciency. Therefore, a system to prevent DNA
degradationwill be expected to signiﬁcantly enhance gene expression
efﬁciency for in vivo therapy. Encapsulation of the DNA within
liposomes would be useful for practical gene therapy because the
liposomal membranewould limit accessibility of DNase. However, due
to its large mass molecular weight, pDNA is difﬁcult to encapsulate
within the internal phase of liposomes. Cationic compounds, such as
poly-L-lysine (PLL), [11,12] and polyethyleneimine (PEI) [13], have
been used to condense the DNA in order to facilitate encapsulation
within liposomes. However, these cationic compounds sometimes
display high levels of cytotoxicity. By contrast, Jeffs et al. reported the
spontaneous free pDNA encapsulationwithin liposomes by optimizing
ethanol concentration, buffer pH and ionic strength [14]. Indeed,
polyethyleneglycol (PEG)-lipids and cationic lipids were utilized in
the liposomal membrane for stabilization and for providing positively
charged liposomes [15,16].
Cationic liposomes are usually composed of cationic lipids such as
didecyldimethylammonium bromide (DDAB) [17,18], 1,2-dipleoyl-3-
dimethylammoniumpropane (DODAP) [14] or N-[1-(2,3-dioleoyloxy)
propyl]-N,N,N-trimethylammonium methyl-sulfate (DOTAP) [19].
Moreover, various cationic lipid structures have been reported to
improve lipoplex-mediated transfection. Indeed, we have reported the
high utility of cationic lipids comprising a lysine or arginine head
group as comparable transgenic reagents [20]. Moreover, the amino-
acid based cationic lipids display very low levels of cytotoxicity
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based transgenic reagents. Therefore, we fully anticipate these amino-
acid based cationic lipids to be promising liposomal components for
the construction of efﬁcient and safe gene carrier systems. However,
the cationic lipids were only investigated in the lipoplex system so far.
Therefore, we explored the most appropriate lipid structure for
construction of pDNA-encapsulating liposomes.
The pDNA-encapsulating liposomes generally fuse to endosomal
membranes by electrostatic interaction between the cationic liposo-
mal membrane and the biomembrane after cellular endocytosis [21–
23]. For efﬁcient transfection, pDNA-encapsulating cationic liposomes
are required to then release the encapsulated pDNA into the
cytoplasm. Thus, the fusion process is the most important factor in
determining gene expression efﬁciency [24,25]. In order to improve
the fusogenic potential of the cationic liposomes with the endosomal
membrane, we concentrated on the spacer unit between the cationic
head group and hydrophobic moieties of the lipids oriented on the
liposomal membrane. This is because the hydrophobic component of
the lipid is preferably fused to the cellular membrane. Few reports
suggested that the hydrophilic or hydrophobic spacers of the cationic
lipids inﬂuenced gene expression, although they were evaluated only
in the lipoplex system [26–28]. We investigated the inﬂuence of the
spacer unit in order to improve intracellular pDNA delivery using the
pDNA-encapsulating liposomes in vitro.
In this paper, we synthesized a series of cationic lipids having a
hydrophilic or hydrophobic spacer to evaluate the effect of the spacer
on gene expression efﬁciency using the pDNA-encapsulating lipo-
somes. We constructed either a hydrocarbon chain of various lengths
or an oxyethylene chain as hydrophobic or hydrophilic spacer units for
the cationic lipids, respectively. The cationic liposomes were thenScheme 1. Syntheses of the cationic lipidexamined in terms of zeta potential, cellular uptake efﬁciency using
COS-1 cells, fusogenic potential to biomembranes, resistance to DNase
and gene expression efﬁciency. The appropriate spacer type and
length were determined by comparison with a non-spacer type lipid;
1,5-dihexadecyl N-lysyl-L-glutamate.
2. Materials and methods
2.1. Materials
The following reagents were purchased from Tokyo Chemical
Industry Co., Ltd. (Tokyo, Japan): 4-aminobutyric acid, 6-aminohex-
anoic acid, and 12-aminolauric acid. p-toluenesulfonic acid mono-
hydrate (p-Tos), benzotriazol-1-yloxytris(dimethylamino)
phosphonium hexaﬂuorophosphate (BOP), tetradecyl alcohol and
hexadecyl alcohol. Octadecyl alcohol was purchased from Kanto
Chemical Co., Ltd. (Tokyo, Japan). 8-Aminocaprylic acid was pur-
chased from Sigma-Aldrich (St. Louis, MO). 1-N-triphenylmethyl-
4,7,10-trioxa-1,13-tridecanediamine-bis[2-(3-aminopropoxy)ethyl]
ether (Trt-diamino-(PEG)2-NH2) was purchased from Cosmo Bio Co.,
Ltd. (Tokyo, Japan). Nα,Nɛ-Di-tert-butoxycarbonyl-L-lysine hydroxy-
succinimide ester (Boc-Lys(Boc)-OSu) and di-tert-butyl dicarbonate
were obtained from Kokusan Chemical Co., Ltd. (Tokyo, Japan). All
organic reagents employed in the syntheses of the cationic lipids were
purchased from Kanto Chemical (Tokyo, Japan). Dioleoylphosphati-
dylcholine (DOPC) and cholesterol were purchased from Nippon Fine
Chemical Co., Ltd. (Osaka, Japan) and utilized without further
puriﬁcation. Poly(ethylene glycol)-1,5-octadecyl-L-glutamate (PEG:
Mw5000, PEG-Glu2C18) [29] and 1,5-dihexadecyl N-lysyl-L-glutamate
[20] were synthesized in our laboratory.s having a hydrocarbon-type spacer.
1150 Y. Obata et al. / Biochimica et Biophysica Acta 1788 (2009) 1148–11582.2. Syntheses
2.2.1. Syntheses of cationic lipids 2a–2d containing a hydrocarbon
chain spacer
We constructed hydrocarbon chain spacers with different carbon
lengths from an ammonioalkanoic acid as shown in Scheme 1. 4-
Aminobutyric acid (5 g, 48.5 mmol), 6-aminohexanoic acid (5 g,
38.2mmol), 8-aminooctanoic acid (5 g, 31.4mmol), or 12-aminolauric
acid (5 g, 23.3 mmol) was dissolved in 100 mL methanol, and then
triethylamine, and 1.1 amount of di-t-butyl dicarbonate ((Boc)2O) to
the ammonioalkanoic acid group was added to the solution,
respectively. After stirring for 12 h at 60 °C, the solvent was
evaporated. Ethyl acetate (100 mL) was added to the remaining sticky
liquid. The ethyl acetate solution was treated with a 0.2-N hydro-
chloride solution (100 mL×2) and washed with distilled water
(100 mL×2). After the solution was evaporated, N-butoxycarbonyl-
aminobutyric acid, N-butoxycarbonyl-aminohexanoic acid, N-butox-
ycarbonyl-aminooctanoic acid and N-butoxycarbonyl-aminolauric
acid (Compound II in Scheme 1) was recrystallized from hexane
(100mL) at 4 °C to obtain awhite powder with yields of 71%, 72%, 35%,
and 84%, respectively.
For the construction of 2a (1,5-dihexadecyl-N-lysyl-N-trityl-L-
glutamate), 2b (1,5-dihexadecyl-N-lysyl-N-pentyl-L-glutamate), 2c
(1,5-dihexadecyl-N-lysyl-N-heptyl-L-glutamate), and 2d (1,5-dihex-
adecyl-N-lysyl-N-undecyl-L-glutamate), the amino-group protected
N-butoxycarbonyl-aminobutyric acid (0.751 g, 3.7 mmol), N-
butoxycarbonyl-aminohexanoic acid (0.855 g, 3.7 mmol), N-
butoxycarbonyl-aminooctanoic acid (0.958 g, 3.7 mmol) or N-
butoxycarbonyl-aminolauric acid (1.17 g, 3.7 mmol) was dissolved
in dichloromethane (100 mL), respectively. Then, benzotriazol-1-
yloxytris(dimethylamino)phosphonium hexaﬂuorophosphate (BOP,
4.07 mmol) was added to the solution to activate the carboxyl
group. After stirring with 1,5-dihexadecy glutamate for 12 h at room
temperature, the solution was treated with a sodium carbonate
solution (100 mL×2) and washed with distilled water (100 mL×2).
After the solutionwas evaporated,1,5-dihexadecyl-N-butoxycarbonyl-
N-trityl-L-glutamate, 1,5-dihexadecyl-N-butoxycarbonyl-N-pentyl-L-
glutamate, 1,5-dihexadecyl-N-butoxycarbonyl-N-heptyl-L-glutamate,
or 1,5-dihexadecyl-N-butoxycarbonyl-N-undecyl-L-glutamate (Com-
pound III in Scheme 1) was recrystallized from methanol (100 mL) at
4 °C to obtain awhite powder. The powderwas dissolved in chloroform
(10mL), and then triﬂuoroacetate (10mL)was added to the solution to
remove the Boc group. After incubation for 2 h at 4 °C, the solutionwas
treated with a sodium carbonate solution (100 mL×2) and washed
with distilled water (100 mL×2). After the chloroform solution was
evaporated, 1,5-dihexadecyl-N-trityl-L-glutamate, 1,5-dihexadecyl-N-
pentyl-L-glutamate, 1,5-dihexadecyl-N-heptyl-L-glutamate, or 1,5-
dihexadecyl-N-undecyl-L-glutamate (Compound IV in Scheme 1)
was obtained as a white powder with yields of 58%, 48%, 56%, or 54%
respectively.
1,5-dihexadecyl-N-trityl-L-glutamate (1 g, 1.47 mmol), 1,5-dihex-
adecyl-N-pentyl-L-glutamate (1 g, 1.42 mol), 1,5-dihexadecyl-N-
heptyl-L-glutamate (1 g, 1.37 mmol), or 1,5-dihexadecyl-N-undecyl-
L-glutamate (1 g, 1.29 mmol) was added to dichloromethane
(100 mL), and then trimethylamine (1.51 mmol) and Boc-Lys(Boc)-
OSu (1.5 mmol) were added to each solution. After stirring for 12 h,
the solution was treated with a sodium carbonate solution
(100 mL×2) and washed with distilled water (100 mL×2). When
the chloroform solutionwas evaporated, 2a, 2b, 2c or 2dwas obtained
after deprotection of Boc group with TFA with yields of 57%, 35%, 45%
or 39%, respectively.
2a: Rf: 0.1 (CHCl3/CH3OH/H2O (65/25/4)), 1H-NMR (CDCl3,
500 MHz, δ ppm): 0.88 (t, 6H, CH2CH3); 1.20–1.34 (br, 54H, CH2),
1.42–1.52 (m, 2H, NHCH2CH2CH2CO), 1.54–1.71 (m, 6H, OCOCH2CH2,
NH2CH2CH2) 1.76–1.86 (m, 2H, NH2CH(CO)CH2), 1.98–2.13 (m, 2H,
CONHCHCH2), 2.28 (t, 2H, NHCOCH2), 2.35–2.47 (m, 2H, CH2COO),2.92 (t, 2H, NH2CH2), 3.25–3.30 (m, 2H, CONHCH2),3.43–3.47 (m, 1H,
NH2CH), 4.05–4.12 (m, 4H, COOCH2), 4.50–4.57 (m, 1H, CONHCH),
7.36(d, 1H, CHNH), 7.82(t, 1H, CH2NH). MS(ESI): (M+H)+ calcd. for
C47H92N4O6, 809.7; found, 809.9.
2b: Rf: 0.1 (CHCl3/CH3OH/H2O (65/25/4)), 1H-NMR (CDCl3,
500 MHz, δ ppm): 0.88 (t, 6H, CH2CH3); 1.20–1.35 (br, 58H, CH2),
1.40–1.51 (br, 4H, CONHCH2CH2, NH2CH2CH2) 1.52–1.68 (m, 6H,
OCOCH2CH2, NH2CH(CO)CH2), 1.81–1.99 (m, 2H, CONHCHCH2), 2.13–
2.25 (br, 2H, NHCOCH2), 2.33–2.41 (m, 2H, CH2COO), 2.90–2.98 (br,
2H, NH2CH2), 3.16–3.25 (br, 2H, CONHCH2),3.75–3.90 (m,1H, NH2CH),
4.02–4.13 (m, 4H, COOCH2), 4.53–4.56 (m, 1H, CONHCH), 7.09(d, 1H,
CHNH), 8.19(t, 1H, CH2NH). MS(ESI): (M+H)+ calcd. for C49H96N4O6,
837.7; found, 837.8.
2c: Rf: 0.1 (CHCl3/CH3OH/H2O (65/25/4)), 1H-NMR (CDCl3,
500 MHz, δ ppm): 0.88 (t, 6H, CH2CH3); 1.14–1.34 (br, 60H, CH2),
1.40–1.52 (br, 2H, NHCOCH2CH2) 1.54–1.70 (m, 8H, OCOCH2CH2,
NH2CH2CH2, CONHCH2CH2), 1.75–1.82(m, 2H, NH2CH(CO)CH2), 1.92–
2.24 (m, 2H, CONHCHCH2), 2.21 (t, 2H, NHCOCH2), 2.30–2.46 (m, 2H,
CH2COO), 2.85 (t, 2H, NH2CH2), 3.16–3.24 (m, 2H, CONHCH2), 3.34–
3.76 (m, 1H, NH2CH), 4.02–4.15 (m, 4H, COOCH2), 4.57–4.61 (m, 1H,
CONHCH), 6.47(d, 1H, CHNH), 7.52(t, 1H, CH2NH). MS(ESI): (M+H)+
calcd. for C51H100N4O6, 865.8; found, 866.1.
2d: Rf: 0.1 (CHCl3/CH3OH/H2O (65/25/4)), 1H-NMR (CDCl3,
500 MHz, δ ppm): 0.88 (t, 6H, CH2CH3); 1.14–1.34 (br, 68H, CH2),
1.40–1.52 (br, 2H, NHCOCH2CH2) 1.52–1.71 (m, 8H, OCOCH2CH2,
NH2CH2CH2, CONHCH2CH2), 1.78–1.86(m, 2H, NH2CH(CO)CH2), 1.94–
2.24 (m, 2H, CONHCHCH2), 2.21 (t, 2H, NHCOCH2), 2.30–2.46 (m, 2H,
CH2COO), 2.80 (t, 2H, NH2CH2), 3.10–3.24 (m, 2H, CONHCH2), 3.33–
3.40 (m, 1H, NH2CH), 4.02–4.14 (m, 4H, COOCH2), 4.58–4.62 (m, 1H,
CONHCH), 7.60(d, 1H, CHNH), 8.21(t, 1H, CH2NH). MS(ESI): (M+H)+
calcd. for C55H108N4O6, 1026.8; found, 1026.9.
2.2.2. Synthesis of the cationic lipid 3a containing an oxyethylene-type
spacer
1,5-Dihexadecyl-L-glutamate (3.5 g, 5.87 mmol) was dissolved in a
solution (50 mL) of dichloromethane/tetrahydrofuran (1/1), and then
succinic anhydride (0.88 g, 8.81mmol) was added to the solution. After
stirring for 12 h at room temperature, the solution was dropped into
500 mL of acetone and cooled to 4 °C. After ﬁltration through a glass
ﬁlter, the 1,5-dihexadecyl-N-succinic-L-glutamate was obtained in a
yield of 85%. 1,5-Dihexadecyl-N-succinic-L-glutamate (1.66 g,
2.39 mmol) and BOP reagent (1.12 g, 2.82 mmol) were dissolved in
dichloroform (100 mL), and then 1-N-triphenylmethyl-4,7,10-trioxa-
1,13-tridecanediamine-bis[2-(3-aminopropoxy)ethyl] ether (trt-
(PEG)2-NH2, 1 g, 2.16 mmol) was added to the solution. After stirring
for 12 h at room temperature, chloroform was evaporated, and the
residue was puriﬁed by column chromatography (silica gel; CHCl3/
MeOH=5/1 (v/v)) resulting in Compound VIII (Scheme 2). After
deprotection of the Boc-group with TFA as described above, Compound
IXwas obtained. Compound IX (500mg, 0.56mmol), Boc-Lys(Boc)-OSu
(280 mg, 0.62 mmol) and triethylamine (0.62 mmol) were added to
dichloromethane (50mL), and the solutionwas stirred for 12 h at room
temperature. After evaporation, the residue was puriﬁed by column
chromatography (silica gel; CHCl3/MeOH=20/1 (v/v)) resulting in
Compound X. After deprotection of the Boc-group, 3awas obtained as a
white powder with a yield of 39%.
3a: Rf: 0.08 (CHCl3/CH3OH/H2O (65/25/4)), 1H-NMR (CDCl3/
MeOD=4/1, 500 MHz, δ ppm): 0.88 (t, 6H, CH2CH3); 1.14–1.34 (br,
52H, CH2), 1.46–1.52 (br, 2H, CHCH2CH2) 1.58–1.66 (m, 4H,
OCOCH2CH2), 1.69–1.81(m, 6H, NH2CH(CO)CH2, CONHCH2CH2), 1.82–
1.89 (m, 2H, NH2CH2CH2), 1.93–2.19 (m, 2H, CONHCHCH2), 2.33–2.41
(m, 2H, CH2COO), 2.45–2.55 (m, 2H, NHCOCH2), 2.96 (t, 2H, NH2CH2),
3.25–3.34 (m, 4H, CONHCH2),3.50–3.65 (br,12H, OCH2), 3.88–3.92 (m,
1H, NH2CH), 4.02–4.15 (m, 4H, COOCH2), 4.46–4.51 (m, 1H, CONHCH),
6.27(d, 1H, CHNH), 7.35(t, 1H, CH2NH). MS(ESI): (M+H)+ calcd. for
C51H100N4O6, 922.1; found, 921.8.
Scheme 2. Syntheses of the cationic lipid having an oligoxyethylene-type spacer.
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pressure liquid chromatography system (Shimadzu Co., Kyoto, Japan;
mobile phase of 50% isopropanol and 0.1% triﬂuoroacetic acid at
0.5 mL/min) using linear gradients starting from 50% isopropanol to
100% in 10 min on a TSK-GEL ODS-80Ts reversed phase column
(TOSOH, Tokyo, Japan) to conﬁrm the purity.
2.3. Liposome preparation
pDNA-encapsulating liposomes were prepared by spontaneous
entrapment of pDNA upon electrostatic interaction with ethanol-
destabilized cationic liposomes [14]. The plasmid vector phRL-TK
(Promega, Madison, WI) encoding luciferase was used for all
experiments. Propagation of the vector was performed by heat shock
transformation into Escherichia coli JM109 and growth in LB medium
supplementedwith 50 μg/mL ampicillin. The pDNAwas isolated using
a QIAGEN Plasmid Mega kit (Qiagen, Germantown, MD). In order to
prepare pDNA-encapsulating liposomes, a pDNA solution was diluted
with 20 mM phosphate buffer (pH 5.0) to achieve a pDNA concentra-
tion of 0.1mg/mL. The driedmixed lipid powder (Table 1) prepared by
freeze-drying from t-butyl alcohol was dissolved in ethanol, and then
the solution was diluted with distilled water to achieve an ethanol
concentration of 90 vol.%. Equal volumes (1 mL) of the pDNA solution
and the resulting lipid solutionweremixed and then incubated at 37 °C
to prepare a liposomal dispersion. After 1 h incubation, the solution
was washed with 20 mMHEPES buffer (pH 7.4) by ultracentrifugationTable 1
Characteristics of pDNA-encapsulating liposomes containing synthetic cationic lipids having
Lipid components Mole ratio Diameter
[nm]
DOPC/cholesterol/PEG-Glu2C18 5/5/0.03 198±81
1a/DOPC/cholesterol/PEG-Glu2C18 1/5/5/0.033 174±66
2a/DOPC/cholesterol/PEG-Glu2C18 1/5/5/0.033 248±99
2b/DOPC/cholesterol/PEG-Glu2C18 1/5/5/0.033 186±69
2c/DOPC/cholesterol/PEG-Glu2C18 1/5/5/0.033 229±91
2d/DOPC/cholesterol/PEG-Glu2C18 1/5/5/0.033 N.D.
3a/DOPC/cholesterol/PEG-Glu2C18 1/5/5/0.033 203±78(100,000×g, 30 min, 4 °C) and dispersion twice. Then, anion exchange
chromatography using DEAE-Sepharose CL-6B (Sigma-Aldrich, St.
Louis, MO) was used to remove the non-encapsulated pDNA and
the pDNA electrostatically adsorbed on the outer surface of the
liposomes. For the analysis of the cellular uptake efﬁciency of the
liposomes, the mixed lipids containing N-(7-nitrobenz-2,1,3-benzox-
adiazol-4-yl)-1,2-dipalmytoyl-sn-phosphatidylethanolamine (NBD-
PE, Avanti Polar Lipids, Inc., Alabaster, AL), at a concentration of
0.1 mol%, were alternatively prepared. The ﬂuorescence labeled
liposomes were then prepared in 20 mM phosphate buffer instead of
pDNA solution as described in the preparation of the pDNA-
encapsulating liposomes.
2.4. Liposomal contents
The lipid concentration of the liposomes was calculated from a
DOPC content determined by a phospholipid C Test WAKO kit (Wako
Pure Chemical Industries, Ltd., Osaka, Japan). The liposome disper-
sions ([lipid]=5mg/mL,10 μL) weremixedwith an equal volume of a
10% SDS solution to solubilize the liposomes. After incubation at 60 °C
for 5 min, the test reagent (3 mL) was added to the solution. Then, the
resulting mixed solutionwas incubated at 37 °C for 3 min according to
the manufacturer's instructions. A DOPC concentrationwas calculated
from the 600 nm absorbance corresponding to production by
cholineoxydase. A total lipid concentration was calculated from the
DOPC content using the feed lipidic molar ratio. The synthetic cationica spacer.
Zeta potential
[mV]
DNA–lipid ratio
(w/w) [×10−3]
Encapsulation
ratio [%]
−0.7±1.3 2.9 10
1.3±1.2 6.2 38
3.3±1.0 4.1 30
3.2±0.9 8.0 49
1.8±0.2 4.6 39
N. D. N.D. N.D.
5.5±1.6 5.6 33
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HPLC system as described earlier. The concentration of pDNA
encapsulated within the liposomes was determined from absorbance
at 260 nm after extracting pDNA with chloroform/ethanol as
described below. The liposome dispersions (50 μL) were ultracen-
trifuged (100,000×g, 30 min) to collect the liposomes. Next, chloro-
form (900 μL) was added to the liposome pellet to dissolve the lipid in
the organic layer. Then, distilled water (100 μL) was added to the
chloroform solution to transfer the pDNA into the water layer. Finally,
pDNA in the water layer was extracted with isopropanol, followed by
70% ethanol addition. The concentration of pDNA dissolved in 20 mM
HEPES buffer was calculated from the 260 nm absorbance using a
Nano Drop ND-1000 (SCRUM Inc. Tokyo, Japan). The pDNA encapsula-
tion ratio represented using the following (1):
Encapsulation ratio kð Þ
= amount of pDNA extracted from the pDNAencapsulating liposomes μgð Þð
= amount of total pDNA used in preparation 100μgð ÞÞ × 100: ð1Þ
2.5. Size distribution of the cationic liposomes
A dispersion of the liposomes (5 μL) containing 10 mg/mL lipid was
diluted with 3mL of 20mMHEPES buffer tomeasure the liposome size.
Then, the mean particle diameter was measured three times with a
dynamic light scattering spectrophotometer (N4 PLUS Submicron
Particle Size Analyzer, Beckman-Coulter, Fullerton, FL). The data
represents an average diameter and a standard deviation (S.D.) value
obtained from measurements performed in triplicate.
2.6. TEM observation of the pDNA-encapsulating cationic liposomes
The pDNA-encapsulating liposomes were observed by transmis-
sion electron microscopy (TEM). A drop of the sample dispersion
([lipid]=100 μg/mL) was placed on a 100mesh copper grid, and then
the excess dispersion was removed with a piece of ﬁlter paper. A 2%
phosphotungstic acid solution (pH 7.4) was dropped on the grid and
then dried for 12 h in a desiccator. The morphology of the cationic
liposomes was observed with TEM (JM-1011, JEOL).
2.7. Zeta potential of the cationic liposomes
The zeta potential of the resulting cationic liposomes at pH 7.4 was
measured with a Zetasizer (Zetasizer4, Malvern, U.K.). The liposome
dispersions ([lipid]=0.1 mg/mL) in 20 mM HEPES buffer (pH 7.4)
were loaded in a capillary cell mounted on the apparatus and
measured three times at 37 °C. The data represents average zeta
potential and a standard deviation (S.D.) value from measurements
carried out in triplicate.
2.8. DNase digestion assay
The pDNA encapsulation within the cationic liposomes was
investigated using DNase. The following samples were tested: naked
pDNA, liposomes with the pDNA (lipoplexes), and the pDNA-
encapsulating liposomes. pDNA (500 ng) was incubated with 500 U
of DNase I (Invitrogen, Carlsbad, CA) in a total volume of 100 μL HEPES
buffer (pH 7.4) for 60 min at 37 °C. The resulting solution was then
extracted by sequential addition of 900 μL of chloroform and 500 μL of
ethanol. After centrifugation (20,400×g) for 30 min, the supernatant
was decanted, and the pDNAwas puriﬁed with 70% ethanol and dried.
The resulting pDNA pellet was dissolved in 10 μL of 20 mM HEPES
buffer (pH 7.4) and analyzed by gel electrophoresis using a 1% agarose
gel in Tris–acetate-EDTA. After electrophoresis for 60 min, the agarose
gel was rinsed in an ethidium bromide solution for 10 min, washed in
distilled water for 15 min, and visualized on a UV transilluminator
(GelDoc XR system; Bio-Rad, Hercules, CA).2.9. Cellular uptake of the cationic liposomes
COS-1 cells (Transformed African green monkey kidney ﬁbroblast
cells, 1×104 cells/well) were seeded on a 96-well plate cell culture
dish and incubated in a humidiﬁed 5% CO2 incubator at 37 °C. After
overnight incubation, the medium in the cell culture dish was
exchanged with fresh Dulbecco's Modiﬁed Eagle Medium (DMEM)
containing the ﬂuorescent labeled liposomes ([lipid]=3 μg/mL as a
ﬁnal concentration of the liposomes). After incubation at 37 °C for 2 h,
the cells were washed twice with a cold PBS solution, and dissolved in
0.1% SDS-containing 5 mM Tris buffer (100 μL, pH 7.4). The amount of
the NBD-PE in the lysate was ﬂuorometrically determined at an
excitation wavelength of 488 nm and an emission wavelength at
530 nm with an ARVO MX-3 (PerkinElmer Japan Co., Ltd, Japan). The
standard curve of NBD-PE ﬂuorescent intensity to lipid concentration
was constructed for each investigated cationic liposome in advance.
The amount of lipid introduced into the cells was then calculated from
the ﬂuorescent intensity of the NBD molecules, followed by
extrapolation using a standard curve. The protein concentration of
the lysate was determined using a standard protein assay (Bio-Rad
Protein Assay, Bio-Rad). Thus, the cellular uptake efﬁciency was
quantitatively estimated and represented as the amount of liposomes
per cellular protein. The data represents average cellular uptake
efﬁciency and a standard deviation (S.D.) value from measurements
performed in triplicate.
2.10. Fusogenic potential of the cationic liposomes
Membrane fusion between the cationic liposomes and liposomes
composed of a biomembrane mimicking lipid composition was
investigated using a ﬂuorescence resonance energy transfer (FRET)
assay [20,30]. The biomembrane mimicking lipid composition, DOPC/
DOPE/DOPS/cholesterol (45/20/20/15, wt.%), was both incorporated
with 1 mol% NBD-PE and N-(lissamine rhodamine B sulfonyl)-1,2-
dipalmytoyl-sn-phophatidylethanolamine (Rh-PE, Avanti Polar Lipids
Inc., Alabaster, AL) to themixed lipids. For the fusion assay, the labeled
liposomes (500 μM, 500 μL) were mixed with the cationic liposomes
(lipids; 500 μM, 500 μL). Then, the mixed solution was incubated at
37 °C for the appropriate time. The transition in ﬂuorescence intensity
was continuously recorded with excitation at 460 nm and emission at
525 nm. The lipidmixing ratio between the cationic liposomes and the
biomembrane mimicking liposomes was determined using the
following equation (2):
Lipid mixing ratiok = Ft − F0ð Þ= FTX − F0ð Þð Þ × 100 ð2Þ
where Ft is the ﬂuorescence intensity at an appropriate time and F0 is
the ﬂuorescence intensity just after dilution with distilled water and
FTX is the ﬂuorescence intensity after the addition of Triton X-100
(100 μL) to solubilize the liposomes for estimating the non FRET
conditions to provide 100% fusion value.
2.11. Gene expression efﬁciency of the pDNA-encapsulating liposomes
COS-1 cells were used to evaluate gene expression efﬁciency of the
pDNA-encapsulating cationic liposomes. The COS-1 cells (1×104 cells/
well) were seeded on 96-well plates and incubated at 37 °C under 5%
CO2 overnight. The medium in the cell culture dishes was exchanged
with a fresh medium (100 μL) containing pDNA or the pDNA-
encapsulating cationic liposomes diluted with DMEM ([pDNA]=2 μg/
mL as a ﬁnal concentration). After incubation at 37 °C for 72 h, the cells
were washed twice with an ice-cold PBS solution and then lysed with
the lysis buffer of a luciferase assay kit (Promega, Madison, WI). The
luciferase activity of a 10 μL aliquot of the cell lysate wasmeasuredwith
a Microlumat Plus (EG&G Berthold, BadWilbad, Germany). The protein
concentration of each well was determined by a standard protein
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relative light unit (RLU) per microgram of protein. The data represents
average gene expression efﬁciency and a standard deviation (S.D.) value
from independent measurements performed in triplicate. Indeed, for
comparison between pDNA-encapsulating liposomes and lipoplexes in
terms of gene expression efﬁciency, the pDNA-encapsulating liposomes
and liposome/pDNA lipoplexes related 2c or 3a were added to COS-1
cells to investigate the inﬂuence of pDNA encapsulation. The lipid-to-
pDNA ratio in lipoplexes was set to that of pDNA-encapsulating
liposomes (2a: 217, 3a: 179 (w/w)). Then, the gene expression studies
were performed as described above. Furthermore, gene expressionwas
compared with that of Lipofectamine™2000 (LA™2000). The
LA™2000-mediated transfection was performed according to the
manufacturer's guidelines.
2.12. Cytotoxicity of the cationic liposomes
The cytotoxicity of the liposome-containing cationic lipids
having different spacer units was investigated using COS-1 cells.
The COS-1 cells (1×104 cells) were seeded on a 96-well plate and
incubated at 37 °C under 5% CO2 overnight. The COS-1 cells were
cultured with DMEM containing 10% FBS. The medium in the cell
culture dish was exchanged with a fresh medium (100 μL)
containing an appropriate concentration of liposomes. After
incubation at 37 °C for 72 h, the medium was exchanged with a
medium (110 μL) containing a tetrazolium salt (WST-1) and
incubated for 30 min. Formazan (absorbance at 540 nm) is then
produced by succinate-tetrazolium reductase in living cells. The
absorbance at 540 nm was monitored using a microplate reader
(Perkin Elmer Japan Co. Ltd, Tokyo, Japan).
3. Results and discussion
3.1. Liposomal contents
We synthesized a series of lipids with a hydrocarbon chain spacer
containing 3, 5, 7, or 11 carbon atoms or an oxyethylene chain spacer
with ten carbon and three oxygen atoms. The hydrophobic moiety;
1,5-dihexadecyl-L-glutamate, was utilized for all cationic lipids. To
introduce the hydrocarbon chain spacer, ammonioalkanoic acid
derivatives with different carbon numbers were reacted with the
1,5-dihexadecyl-L-glutamate via an amide linkage as shown in Scheme
1. Then, after introducing a lysine moiety as a cationic head group, we
obtained cationic lipids having the different hydrocarbon chain
spacers (2a–2d). Alternatively, 3a having an oxyethylene chain spacer
was introduced from 1,5-dihexadecyl-N-succinyl-L-glutamate. Thus,
we succeeded in devising an efﬁcient synthetic route to generate a
series of cationic lipids containing various spacers using a minimum
number of steps. When the cationic liposomes containing the
synthetic lipids were prepared, the ratio of the cationic lipids toChart 1. Chemical structure of the comliposomal membrane was conﬁrmed using HPLC analysis. Then, the
concentration of the cationic liposomal components was conﬁrmed to
be the same as that prepared in mixed lipids. Indeed, the 2d assembly
tended to aggregate just after preparation. Therefore, no further
analysis on 2d was performed in this study.
The most studied liposomes for gene delivery are composed of
phospholipids and mixed membrane cationic lipids. Phospholipids,
such as dioleoylphosphatidylcholine (DOPC) [31], dimyristoylpho-
phatidylcholine (DMPC) [32,33], and dioleoylphosphatidylethanola-
mine (DOPE) [24,34,35], are frequently utilized as liposomal
components, and cholesterol is also utilized to control membrane
permeability and ﬂuidity. In this study, DOPC and cholesterol were
selected as basicmembrane components of the liposome, of which the
mixed mole ratio was 1:1. Indeed, incorporation of the cationic lipid
or PEG-Glu2C18 to the basic membrane was deﬁned as 10 mol% or
0.3 mol%, respectively because PEG-Glu2C18 is essential in preventing
aggregation during preparation with ethanol. Furthermore, because
excess incorporation of the cationic lipids into liposomal membrane
would alter the vesicular structure, the incorporation ratio was
determined as 10 mol% of the total membrane. We conﬁrmed the
tube-like morphology of liposomes incorporating 50 mol% of cationic
lipids, particularly in the case of 3a (data not shown). By contrast,
liposomes containing 2d having an eleven hydrocarbon spacer
produced aggregates just after extrusion. Presumably this was due
to the particularly hydrophobic nature of the spacer unit of 2d. Using
this approach, we were able to deﬁne the limit to the length of the
hydrocarbon spacer between the head group and hydrophobic
moieties in order to generate stable liposomes.
3.2. pDNA-encapsulating cationic liposomes
The pDNA-encapsulating cationic liposomes containing synthetic
lipids with different spacer units (Chart 1) were prepared by varying
the ethanol concentration before and after addition of the pDNA
solution. The size of the pDNA-encapsulating liposomes was deter-
mined to be within 170–250 nm as shown in Table 1. Furthermore, we
observed the pDNA-encapsulating cationic liposomes by TEM (Fig. 1).
The structures were conﬁrmed to be vesicular having an approximate
diameter of 200 nm, corresponding to the results of the DLS
measurements. Morphology of the cationic liposomes was not
inﬂuenced by the spacer length when 10 mol% cationic lipids (1a,
2a–2c, 3a) were inserted into the liposomal membrane. The pDNA
encapsulating efﬁciency was about 30–49% in the case of liposomes
containing cationic lipids. By contrast, the encapsulating efﬁciency
was only about 10% for basic DOPC/cholesterol liposomes.
We succeeded in preparing pDNA-encapsulating liposomes con-
taining synthetic cationic lipids bearing different spacer units.
Previous studies indicated that ethanol made the lipid membrane
susceptible to structural rearrangements, and ultimately led to
liposome formation [14]. Moreover, incorporation of PEG-lipid to theparable synthetic cationic lipids.
Fig. 1. Transmission electron microscopic images of the pDNA-encapsulating cationic liposomes composed of DOPC, 1a, 2a, 2b, 2c, or 3a. Scale bar indicates 200 nm.
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study, the ratio of 0.3 mol% PEG-Glu2C18 was enough to prepare stable
liposomes having diameters of 150–200 nm. The cationic liposomes
showed extremely higher pDNA encapsulating efﬁciency than DOPC/
cholesterol liposomes. This is presumably because a large number of
the encapsulated pDNAmolecules are electrostatically adsorbed to the
inner leaﬂet of the cationic liposome membrane.
3.3. Zeta potential of the liposomes
The zeta potential depends on the charge density of the cationic
moietyat the surface of the liposomes.We investigated the inﬂuence of
the spacer unit of the cationic lipids on the zeta potential of the
liposomes. DOPC/cholesterol liposomes gave a zeta potential of
around zero (Table 1). The zeta potentials of the 1a, 2a–2c, and 3a
liposomeswere 1.3, 3.3, 3.2,1.8 and5.5mV, respectively. A positive zeta
potential was attained when the cationic lipids were inserted into the
basic DOPC/cholesterol liposomes. Moreover, the degree of the zeta
potential of 2a–2c liposomes was similar to that of 1a liposomes,
though 3a liposomes displayed a slightly greater zeta potential.
Incorporation of cationic lipids 1a, 2a–2c, and 3a generated
positively charged liposomes as compared to the basic DOPC/
cholesterol liposomes. The hydrophobic and hydrophilic spacer unit
of the cationic lipids 2a–2c, 3a did not signiﬁcantly inﬂuence the zeta
potential of the liposomes. However, the slightly high zeta potential of
3a liposomes suggested that the cationic moiety of 3a might beFig. 2. DNase I digestion assay for pDNA encapsulation within the liposomes containing
liposomes. Each sample containing 500 ng pDNA was incubated with (+) or without (−) 5located on the outer most side of the membrane as a result of the
extension of the hydrophilic oligoxyethylene spacer.
3.4. DNase assay
We conﬁrmed pDNA encapsulation within the liposomes by
adding DNase to the pDNA-encapsulating liposomes. Naked pDNA
alone and pDNA/empty liposomes (complex) were readily degraded
by DNase (Fig. 2). By contrast, the DNA in pDNA-encapsulating
liposomes was completely protected from degradation. This result
suggests that the pDNA was efﬁciently encapsulated within the
cationic liposomes and therefore resistant to exogenous DNase.
DNA degradation is known to be a limiting factor in the application
of gene therapy [36,37]. When the lipoplexes are applied to target
tissues under intravenous injection or direct injection into organs, DNA
is subject to degradation and then cleared from the biological system.
Therefore, the protection of DNA from DNase is an absolute require-
ment for practical gene therapy. In this study, we achieved DNA
protection from exogenous DNase by encapsulation of DNA within
liposomes, indicating the liposomal membrane is able to limit DNase
access to encapsulated DNA within the inner aqueous phase.
3.5. Cellular uptake of the cationic liposomes
We investigated the cellular uptake efﬁciency of the cationic
liposomes containing the synthetic cationic lipids using COS-1 cellsthe space embedded lipids. (I) pDNA/liposomes (Complex). (II) pDNA-encapsulating
00 U of DNase I at 37 °C for 1 h.
Fig. 4. Time courses of the fusogenic potential of the cationic liposomes to the
biomembrane mimicking membrane (DOPC/DOPE/DOPS/cholesterol).
Fig. 3. Cellular uptake efﬁciency of the cationic liposomes for 2 h at 37 °C.
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lipids having a lysine head group was higher than that of the DOPC/
cholesterol liposomes. Speciﬁcally, the cellular uptake efﬁciency of 1a
liposomes was ﬁve times higher than that of the DOPC/cholesterol
liposomes. Indeed, cationic liposomes containing the synthetic lipids
2a–2c having a hydrophobic spacer unit showed comparable cellular
uptake efﬁciencies, which were similar to 1a liposomes. Moreover,
cationic liposomes containing lipid with an oxyethylene spacer unit
showed similar cellular uptake efﬁciencies to those containing a
hydrophobic spacer unit.
We conﬁrmed that incorporation of the synthetic cationic lipids to
the basic DOPC/cholesterol membrane increased cellular uptake as a
result of an electrostatic adsorption of the cationic liposomes to the
negatively charged biomembrane, followed by cellular uptake into
COS-1 cells. Liposomes containing lipids 2a–2c and 3a, having a
hydrophobic or hydrophilic spacer unit, displayed similar cellular
uptake efﬁciencies. These observations suggest that the hydrophobic
or hydrophilic characteristics of the spacer unit do not signiﬁcantly
affect cellular uptake. That can be explained by applying the
equivalent zeta potential of the liposomes containing a non-spacer
lipid (1a) and cationic lipids having a spacer unit.
3.6. Fusogenic potential of the cationic liposomes
We also investigated the fusogenic potential of the cationic
liposomes, which is the most important factor for intracellular
pDNA trafﬁcking and for gene expression efﬁciency. As shown in
Fig. 4, the DOPC/cholesterol liposomes showed very limited
fusogenic potential to the biomembrane-mimicking liposomes
(DOPC/DOPE/DOPS/cholesterol). By contrast, liposomes containing
the synthetic cationic lipids with a hydrocarbon-type spacer
enhanced the fusogenic potential. The order of fusogenic potential
over a 5 min period was 2cN2bN2aN3aN1a. In the case of the 2c
liposomes, about 10% were able to fuse after 5 min. Indeed,
fusogenic potential depended on the length of the hydrophobic
spacer unit. Consequently, liposomes displaying the highest fuso-
genic potential were those containing 2c. The fusogenic potential of
3a liposomes, containing an oxyethylene chain spacer, was low. In
the case of 2a liposomes, fusion decreased after showing a
maximum value at 150 s.
The membrane fusion behavior between the cationic liposomes
and the biomembrane-mimicking liposomes is known to provide
information about gene expression efﬁciencies [38–40]. Speciﬁcally,
the experiment mimics fusion of liposomes with the endosome
membrane following endocytosis. After endocytosis of the cationic
liposomes, they are transferred to early endosomes within 5 min [41].Liposomes that are retained by the endosomes are subsequently
transferred into the lysosome within 30 min. For estimating effective
intracellular pDNA delivery, we measured the fusogenic potential of
the liposomes for 5 min, implying pDNA release from the early
endosome. In our study, 2c containing a seven hydrocarbon spacer
revealed the highest fusogenic potential among the series of cationic
lipids. Kono et al. suggested that the hydrophobic nature of the spacer
unit exposes the hydrophilic moiety of the lipids thereby enhancing
the fusogenic potential to a biomembrane by hydrophobic interaction
[42,43]. Therefore, a cationic lipid with a large hydrophobic spacer,
such as 2c, would be expected to give the highest fusogenic potential.
By contrast, the hydrophilic nature of the oxyethylene spacer, as in 3a,
is anticipated to give a low fusogenic potential due to hydrophilic
repulsionwith the endosomal membrane. In the case of 2a liposomes,
the fusion dynamics was different from the other cationic liposomes.
When 2a liposomes adhered to the anionic liposomes by electrostatic
interaction just after mixing, 2a was not diluted into the anionic
membrane and gradually became aggregated. The aggregation would
therefore reduce ﬂuorescent intensity to provide an apparent
reduction of fusogenic potential. Thus, we demonstrated the role of
the hydrocarbon chain spacer between the cationic moiety and the
hydrophobic moieties for improving fusogenic potential.
3.7. Gene expression efﬁciency of the pDNA-encapsulating cationic
liposomes
We investigated the gene expression efﬁciency of the pDNA-
encapsulating cationic liposomes using COS-1 cells. The pDNA-
encapsulating liposomes were added to the cells for various incuba-
tion periods. All the cationic liposomes exhibited the highest gene
expression at 72 h. Therefore, the gene expression efﬁciency at 72 h
was compared between the pDNA-encapsulating liposomes to
evaluate spacer effects (Fig. 5). Our results suggest that the gene
expression level is inﬂuenced by the length and type of spacer unit.
Gene expression efﬁciency varied in the following order:
2cN2a≥2bN3a≥1a. By contrast, 1a, as a non-spacer type lipid,
showed the lowest gene expression efﬁciency among the investigated
lipids. DDAB-containing liposomes, which acted as a positive control,
showed equivalent gene expression efﬁciency to that of the 3a
liposomes.
We ranked the cationic liposomes in terms of level of gene
expression. Intriguingly, this ranking corresponded precisely to that of
the cationic liposomes in terms of fusogenic potential. When cationic
liposomes are introduced into cells by endocytosis, the release of
encapsulated pDNA occurs after fusion of the cationic liposomes to
endosomes. Therefore, because the level of cellular uptake efﬁciency
Fig. 6. Gene expression efﬁciency of the pDNA-encapsulating liposomes, liposome/
pDNA lipoplexes and Lipofectamine™2000 in COS-1 cells. Closed bars indicate gene
expression efﬁciency of pDNA-encapsulating liposomes containing 2c or 3a, respec-
tively. Open bars indicate gene expression efﬁciency of liposome/pDNA lipoplexes with
a same lipid-to-pDNA ratio to pDNA-encapsulating liposomes.
Fig. 7. Cytotoxicity of the liposomes containing cationic lipids having a spacer. The
activity was measured at 72 h after the addition of the liposomes to COS-1 cells. The
lipid concentration in medium represented as ash bar: 1 μg/mL, closed bar: 10 μg/mL,
and line bar: 100 μg/mL.
Fig. 5. Luciferase activity of the pDNA-encapsulating liposomes composed of cationic
lipids. The activity was measured at 72 h after the addition of the liposomes to COS-1
cells.
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efﬁciency is likely to correspond to fusogenic potential. Considering
spacer effects, Bajaj et al. reported that cationic liposomes composed
of the cationic gemini lipids having a hydrophilic spacer between the
two head groups showed higher gene expression efﬁciency in
comparison with the non-spacer type lipid. It was considered that
gemini lipids having the hydrophilic spacer unit between head groups
were able to stabilize the lipoplexes in serum protein [44, 45]. Indeed,
length of the spacer with a hydrocarbon unit was extensively
investigated to clarify inﬂuences of the spacer on phase transition,
and fusion of liposomes by Bhattacharya et al. [28]. The study
suggested that the appropriate length of a spacer between head
groups of gemini lipids displayed high fusion potential. Mahidhar et al.
analyzed cationic lipids having a hydrocarbon spacer unit between the
cationic moiety and the functional sugar [46]. Their results indicated
that the long hydrocarbon spacer diminished gene expression
efﬁciency in comparison with the non-spacer type glycolipid [47].
These previous studies used lipoplex system. By contrast, in our study
the pDNA is located on the internal phase of the liposomes and
clariﬁed the spacer effect. Thus, the different location of the pDNA
within the liposome structure may explain why the role of the spacer
is different from previous studies using spacer embedded lipids. Using
this data we may be able to predict the inﬂuence of the spacer unit
between the cationic head group and hydrophobic moieties in the
pDNA-encapsulating liposomes. Furthermore, the level of gene
expression with 2c was 2-fold higher than that of cationic liposomes
containing DDAB, which is extensively utilized in gene delivery
systems [48,49]. The pDNA-encapsulating liposomes containing DDAB
were also constructed and their properties examined [17,50,51]. Zhang
et al. achieved successful transfection on HepG2 and SMMC-7721
human hepatocellular carcinoma cell lines using the pDNA-encapsu-
lating liposomes containing DDAB [52]. Therefore, we were able to
demonstrate the high gene expression capacity by using the cationic
amino acid-based lipids having a spacer between the cationic and
hydrophobic moieties.
3.8. Inﬂuence of pDNA encapsulation on gene expression efﬁciency
We compared the gene expression efﬁciency of the pDNA-
encapsulating liposomes with the liposome/pDNA lipoplexes and
clariﬁed that the pDNA-encapsulating liposomes showed complete
DNase resistance (Fig. 6). In the case of 2c, which has a hydrocarbon
spacer, the gene expression efﬁciency of the pDNA-encapsulating
liposomeswith a lipid-to-pDNA ratio of 217was higher than that of theliposome/pDNA lipoplexes with the same lipid-to-pDNA ratio (Fig. 6).
Indeed, the gene expression efﬁciency of the pDNA-encapsulating
liposomes was also higher than the liposome/pDNA lipoplexes with a
lipid-to-pDNA ratio of 179, as shown in the case of 3a with an
oxyethylene spacer. The gene expression efﬁciency of the pDNA-
encapsulating 2c liposomeswas 4-fold higher than that of LA™2000 as
a lipoplex system. Therefore, we were able to demonstrate that pDNA
encapsulation within liposomes could effectively improve gene
expression efﬁciency.
The degradation of pDNA by endogenous nucleases can result in
low gene expression efﬁciency. Therefore, inhibition of pDNA
degradation is required in order to obtain efﬁcient transfection. In
this regard, we have already conﬁrmed that pDNA-encapsulating
liposomes are resistant to DNase (Fig. 4). Mok et al. previously
reported that pDNA encapsulated in the stabilized plasmid-lipid
particles inhibited pDNA degradation during intracellular delivery
[53]. Our results for enhancement of gene expression efﬁciency also
indicate that pDNA encapsulation in liposomes can facilitate intracel-
lular delivery by preventing pDNA degradation.
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The cationic liposomes containing synthetic lipids with a spacer
unit displayed relatively low levels of cytotoxicity (Fig. 7). Amongst
these, 2c liposomes showed low cytotoxicity i.e., all cells were
survived for 1 μg/mL of 2c. By contrast, liposomes containing DDAB
as a conventional cationic lipid showed higher levels of cytotoxicity
than any of the cationic lipids with a spacer unit. For example, 30% of
the cells seeded on a culture dish were damaged by the presence of
1 μg/mL DDAB liposome concentration. With the increasing length of
hydrocarbon spacer, the cell cytotoxicity tended to increase slightly
among 1a, 2a–2c.
Thus, the low level of cytotoxicity was conﬁrmed for the amino-
acid based lipids with a spacer unit. Generally, hydrophobicity of the
lipids, which oriented onto the liposomal surface, would be expected
to lead to cytotoxicity because hydrophobic materials facilitate
adherence to cellular membranes by hydrophobic interaction. The
tendency was also conﬁrmed in our study. When we introduced the
hydrophobic spacer into cationic lipid to enhance fusogenic potential,
the cytotoxicity was slightly increased with increasing length of
spacer.
3.10. Conclusions
We synthesized a series of cationic lipids with various spacer units
between the cationic head group and hydrophobic moieties and
investigated their utility in a pDNA-encapsulating liposome mediated
gene delivery system. The pDNA encapsulation, cellular uptake and
fusogenic potential of the cationic liposomes were also investigated.
Fusogenic potential between liposomes and biomembranes depended
on the nature of the spacer (i.e., length and hydrophobicity), which
played an important factor in intracellular pDNA delivery. In our
system, 2c was the most appropriate structure for obtaining the
highest gene expression efﬁciency. In this report, we enhanced the
gene expression of a pDNA-encapsulating liposome mediated gene
delivery by varying the spacer between the cationic head group and
hydrophobic moieties of the cationic lipids. Our results clearly
demonstrate the importance of spacer embedded cationic lipids for
enhancing gene delivery.
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